VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
VSCPX
Price
$408.08
Change
-$0.97 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

VSCIX vs VSCPX

VSCIX vs VSCPX Comparison Chart in %
View a ticker or compare two or three
VS
VSCIX vs. VSCPX commentary
Aug 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCIX is a Hold and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX (189B) and VSCPX (189B) have equal amount of cash in the bank . VSCPX (1.24) and VSCIX (1.23) have matching dividends . VSCIX was incepted earlier than VSCPX: VSCIX (29 years) vs VSCPX (16 years). VSCIX (0.03) is less costly to investors than VSCPX (0.02). VSCIX (17.00) and VSCPX (17.00) have comparable annual turnover. VSCIX has a lower initial minimum investment than VSCPX: VSCIX (5000000) vs VSCPX (100000000). VSCPX (22.59) and VSCIX (22.58) have marching annual gain over last year. VSCPX (35.15) and VSCIX (35.13) have equivalent 5 years return.
VSCIXVSCPXVSCIX / VSCPX
Total Expense Ratio0.030.02150%
Annual Report Gross Expense Ratio0.030.02150%
Fund Existence29 years16 years-
Gain YTD14.59114.596100%
Front LoadN/AN/A-
Min. Initial Investment50000001000000005%
Min. Initial Investment IRAN/AN/A-
Net Assets189B189B100%
Annual Yield % from dividends1.231.2499%
Returns for 1 year22.5822.59100%
Returns for 3 years43.4443.45100%
Returns for 5 years35.1335.15100%
Returns for 10 years156.07156.12100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
PIEQX22.30-0.17
-0.76%
T. Rowe Price International Eq Index
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv